Keryx treatment gets faster FDA review
AP - Wed Dec 2, 3:42 pm ETKeryx Biopharmaceuticals Inc. and AEterna Zentaris Inc. said Wednesday the Food and Drug Administration granted the potential cancer treatment Perifosine a fast-track review process.
4695 Stories, most recent news story added Wed Dec 2, 1:25 pm ET
Keryx Biopharmaceuticals Inc. and AEterna Zentaris Inc. said Wednesday the Food and Drug Administration granted the potential cancer treatment Perifosine a fast-track review process.
An Alameda County, Calif., a jury late last month returned a $50 million verdict in a class action that sought relief for Californians who'd bought Avacor, a hair-loss remedy that was marketed as an all-natural, clinically tested product. The outcome against two defendants marked the second trial victory in the same class action for the plaintiff lawyers. The earlier trial had ended in a $40 ...
LEARN MORE Tyson Foods Web site FDA – Warning Letter IMAGE SOURCE:Tyson Foods Web site Seafood Gumbo Tyson Foods has received a warning letter from the Food and Drug Administration for “serious violations” of food safety standards at its Fort Worth, Texas seafood soup manufacturing plant. FDA inspectors allegedly found fish meat that was to go into seafood gumbo stored at temperatures between 40 ...
SCHAUMBURG, Ill., Dec. 2 /PRNewswire-USNewswire/ -- The American Academy of Dermatology (Academy) applauds the U.S. Food and Drug Administration (FDA) for the recent update to its consumer health information Web pages on indoor tanning, entitled "Indoor Tanning: The Risks of Ultraviolet Rays." These Web pages provide consumers with updated information about all FDA-regulated products. Sunlamps ...
Inspectors found unsanitary conditions at a Tyson Foods plant in Forth Worth, Tex., that makes seafood soups, says a U.S. Food and Drug Administration warning letter sent to the company and posted on the agency's Web site.
NEW YORK, NY--(Marketwire - December 2, 2009) - The Rosen Law Firm, P.A. announces that a class action lawsuit has been filed on behalf of all purchasers of Hemispherx Biopharma Inc. ("Hemispherx") ( NYSE Amex : HEB ) securities between February 18, 2009 and October 30, 2009, inclusive (the "Class Period"). To join the Hemispherx class action, go to the website at http://www ...
BETHESDA, MD - BrainScope Company Inc., a developer of non-invasive hand-held devices that are designed to quickly assess a patient’s brain function, has raised more than $2.5 million in debt and equity financing, according to regulatory filings.
Shares of Dyax Corp. jumped to their highest price in more than a year on Wednesday after regulators approved marketing of the company's hereditary angioedema drug Kalbitor. Dyax stock climbed more than 20 percent in heavy morning trading, and peaked at its... Business - Food and Drug Administration - Stock - Investing - Corporation
NEWARK, Del.----PicksThatMove is pleased to bring investors special situation stocks which have a high potential for price appreciation. These companies have interesting business models and they have to execute on the business development level to bring value to shareholders.
The U.S. Anti-Doping Agency will unveil details of a new plan to confront manufacturers who produce supplements that contain steroids and other dangerous drugs.
BioMarin receives FDA orphan drug status for 3,4-DAP.
Ignorance (and complacency) is anything but bliss when it comes to food safety.
PRINCETON, N.J., Dec. 2 /PRNewswire-FirstCall/ -- Novo Nordisk said today that the U.S.
SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The world is going through extraordinary times; markets are in turmoil and uncertainty is part of many businesses and industries.
QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that the U.S.
NEW YORK, Dec. 2 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that the U.S.